Article2002

Indirect Economic Effects of Long‐Term Breast Cancer Survival

Thomas N. Chirikos · Anita Russell‐Jacobs · Alan B Cantor

130 citations0/0 files storedCancer Practice

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Economic and Financial Impacts of Cancer Cancer survivorship and care Health Systems, Economic Evaluations, Quality of Life

Abstract

PURPOSE: The indirect morbidity/disability costs of breast cancer may be rising as a consequence of the growth in the population of long-term survivors. This study was conducted to test whether women who have survived breast cancer for at least 5 years experience long-lasting or continuing economic consequences that are attributable to their disease. DESCRIPTION OF STUDY: A group of 105 women who initially had been treated for breast cancer approximately 5 years before were interviewed to obtain data on economic, demographic, and health changes in the period since diagnosis. An age-matched and work-matched group of 105 women without cancer also was interviewed to obtain the same data for the same time period. Key changes in the economic position of subjects and their families were measured, including changes in work effort, pay rates, and annual earnings of working women and changes in household earnings, income, and assets of all women. RESULTS: These preliminary empirical findings suggest that breast cancer exacts an economic toll from long-term survivors. In particular, survivors who were working at the time of their diagnosis experienced significantly larger reductions in annual market earnings over the 5-year study period than did working control subjects. These losses appear to arise mostly from reduced work effort, not changes in pay rates. Also, changes in total household earnings were lower for survivors, suggesting the presence of family adjustments to the disease. However, no significant differences were detected between the groups in changes in total income or assets over the study period. CLINICAL IMPLICATIONS: Clinicians and policy makers must seek ways to minimize the indirect economic losses that are attributable to breast cancer.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 130 citations exist upstream.

References

1992The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.1992The MOS 36-ltem Short-Form Health Survey (SF-36)2001The Burden of Illness of Cancer: Economic Cost and Quality of Life

Cited by

2009The Costs of Treating Breast Cancer in the US 2007Exploring the economic impact of breast cancers during the 18 months following diagnosis 2014The personal financial burden of complications after colorectal cancer surgery 2010The out of pocket cost of breast cancer survivors: a review 2017Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States 2013"It's at a Time in Your Life When You Are Most Vulnerable": A Qualitative Exploration of the Financial Impact of a Cancer Diagnosis and Implications for Financial Protection in Health 2014A Composite Measure of Personal Financial Burden Among Patients With Stage III Colorectal Cancer 2004Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.